221 related articles for article (PubMed ID: 36514118)
1. Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.
Wen A; Wang X; Wang B; Yan C; Luo J; Wang P; Li J
Radiat Oncol; 2022 Dec; 17(1):206. PubMed ID: 36514118
[TBL] [Abstract][Full Text] [Related]
2. Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.
Qu HD; Han DM; Zhang N; Mao Z; Cheng GH
Front Oncol; 2020; 10():621347. PubMed ID: 33680943
[TBL] [Abstract][Full Text] [Related]
3. Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix.
Sinnatamby M; Kandasamy S; Karunanidhi G; Neelakandan V; Ramapandian S; Kannan M; Sampath E
Gulf J Oncolog; 2022 Jan; 1(38):7-14. PubMed ID: 35156639
[TBL] [Abstract][Full Text] [Related]
4. Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
Oike T; Ohno T; Noda SE; Kiyohara H; Ando K; Shibuya K; Tamaki T; Takakusagi Y; Sato H; Nakano T
Radiat Oncol; 2014 Oct; 9():222. PubMed ID: 25319341
[TBL] [Abstract][Full Text] [Related]
5. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
6. Estimation and comparison of integral dose to target and organs at risk in three-dimensional computed tomography image-based treatment planning of carcinoma uterine cervix with two high-dose-rate brachytherapy sources:
Yadav S; Singh OP; Choudhary S; Saroj DK; Yogi V; Goswami B
J Cancer Res Ther; 2021; 17(1):191-197. PubMed ID: 33723154
[TBL] [Abstract][Full Text] [Related]
7. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
[TBL] [Abstract][Full Text] [Related]
8. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A
Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016
[TBL] [Abstract][Full Text] [Related]
9. IRIDIUM-192 RADIOTHERAPY BENEFITS IN THE MANAGEMENT OF GYNECOLOGICAL TUMORS.
Ivankova VS; Domina EA; Khrulenko TV; Baranovska LM; Hrinchenko OO
Probl Radiac Med Radiobiol; 2020 Dec; 25():569-578. PubMed ID: 33361862
[TBL] [Abstract][Full Text] [Related]
10. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T
Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits.
Gao J; Xu B; Lin Y; Xu Z; Huang M; Li X; Wu X; Chen Y
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291951
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of
Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
[TBL] [Abstract][Full Text] [Related]
14. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
Dincer N; Ugurluer G; Mustafayev TZ; Serkizyan A; Aydin G; Güngör G; Yapici B; Atalar B; Özyar E
Brachytherapy; 2024; 23(1):18-24. PubMed ID: 38000958
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological comparison between Cobalt-60 and Iridium-192 high-dose-rate brachytherapy sources: Part I-cervical cancer.
Dayyani M; Hoseinian-Azghadi E; Miri-Hakimabad H; Rafat-Motavalli L; Abdollahi S; Mohammadi N
Med Phys; 2021 Oct; 48(10):6213-6225. PubMed ID: 34415623
[TBL] [Abstract][Full Text] [Related]
17. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
18. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
Yan J; Zhu J; Chen K; Yu L; Zhang F
Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of dosimetric and radiobiological models of IPSA and HIPO algorithms in combined intra-cavitary/interstitial brachytherapy for cervical cancer.
Yan C; Wang X; Wen A; Luo J; Zhang S; Wang P; Li J
J Contemp Brachytherapy; 2023 Jun; 15(3):212-219. PubMed ID: 37425198
[TBL] [Abstract][Full Text] [Related]
20. A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with "intentional internal high-dose policy" high-dose-rate interstitial brachytherapy.
Kashihara T; Kobayashi K; Iijima K; Murakami N; Yoshida K; Okuma K; Nakamura S; Takahashi K; Inaba K; Igaki H; Nakayama Y; Kato T; Uno T; Itami J
Medicine (Baltimore); 2020 Jul; 99(27):e20860. PubMed ID: 32629674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]